Estrogen And Alzheimers

Estrogen, a hormone primarily involved in female reproductive health, has been linked to Alzheimer's disease (AD) and dementia. Research suggests that estrogen has neuroprotective properties, potentially reducing the risk of AD. It influences brain function by promoting synaptic plasticity, enhancing cerebral blood flow, and reducing inflammation. Postmenopausal women, who experience a significant drop in estrogen levels, show a higher incidence of AD, implying a connection between estrogen deficiency and cognitive decline. Hormone replacement therapy (HRT) has been explored as a preventive measure; however, its efficacy and safety remain controversial, with studies showing mixed results. Understanding estrogen's role in neuroprotection could lead to new therapeutic strategies for combating Alzheimer's and other dementias.

Committee Members
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - London Jacqueline

London Jacqueline

Paris Diderot University, France
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jacqueline Tuppen

Jacqueline Tuppen

Cogs Club, United Kingdom
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Zhenhuan Liu

Zhenhuan Liu

Guangzhou University of Chinese Medicine, China
Tags

Submit your abstract Today

Whatsapp